Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 19.
Published in final edited form as: Int J Cardiol. 2018 Oct 23;282:7–15. doi: 10.1016/j.ijcard.2018.10.073

Accuracy of Non-invasive Stress Testing in Women and Men with Angina in the Absence of Obstructive Coronary Artery Disease

Vedant S Pargaonkar 1, Yuhei Kobayashi 1, Takumi Kimura 1, Ingela Schnittger 1, Eric KH Chow 2, Victor F Froelicher 1, Ian S Rogers 1, David P Lee 1, William F Fearon 1, Alan C Yeung 1, Marcia L Stefanick 3, Jennifer A Tremmel 1
PMCID: PMC9017854  NIHMSID: NIHMS1515945  PMID: 30527992

Abstract

Objective:

While >20% of patients presenting to the cardiac catheterization laboratory with angina have no obstructive coronary artery disease (CAD), a majority (77%) have occult coronary abnormality (endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB)). There is little data regarding the ability of noninvasive stress testing to identify these occult abnormalities in patients with angina in the absence of obstructive CAD.

Methods:

We retrospectively evaluated 155 patients (76.7% women) with angina and no obstructive CAD who underwent stress echocardiography and/or electrocardiography before angiography. We evaluated Duke treadmill score, heart rate recovery (HRR), metabolic equivalents, and blood pressure response. During angiography, patients underwent invasive testing for endothelial dysfunction (decrease in epicardial coronary artery diameter > 20% after intracoronary acetylcholine), MVD (index of microcirculatory resistance ≥ 25) and intravascular ultrasound for presence of an MB.

Results:

Stress echocardiography and electrocardiography were positive in 58 (43.6%) and 57 (36.7%) patients, respectively. Endothelial dysfunction was present in 96 (64%), MVD in 32 (20.6%), and an MB in 83 (53.9%). On multivariable logistic regression, stress echo was not associated with any abnormality, while stress ECG was associated with endothelial dysfunction. An abnormal HRR was associated with endothelial dysfunction and MVD, but not an MB.

Conclusion:

Conventional stress testing is insufficient for identifying occult coronary abnormalities that are frequently present in patients with angina in the absence of obstructive CAD. A normal stress test does not rule out a non-obstructive coronary etiology of angina, nor does it negate the need for comprehensive invasive testing.

Keywords: Electrocardiography, Echocardiography, Coronary artery disease, angina

1. INTRODUCTION

More than 20% of patients undergoing coronary angiography (CA) have no significant obstructive coronary artery disease (CAD) despite anginal symptoms.[1] Several occult coronary abnormalities can be identified in these patients, including endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB), which may explain their symptoms.[2] Previous studies have reported worse outcomes in this patient population,[3] with a higher burden of hospitalization, repeat CA, and higher healthcare cost.[4,5] Current clinical practice guidelines are also not helpful in the management of these patients as current diagnostic criteria for CAD are not met.[6] Invasive cardiac catheterization including endothelial function testing, coronary physiology measurements, and intravascular ultrasound (IVUS) are suggested to be the gold standard tests for identifying these occult coronary abnormalities.[79]

Stress echocardiography (echo) and stress electrocardiography (ECG) are non-invasive tests considered integral in the evaluation of patients with known or suspected CAD.[10] The diagnostic value of these tests has been proven in identifying obstructive CAD, but little data are available regarding their ability to evaluate the source of angina in patients with non-obstructive CAD. A previous study by Cassar et al. reported that noninvasive stress tests have limited diagnostic accuracy for identifying coronary vasomotor dysfunction in patients with no obstructive CAD.[11] Specifically, they found that stress echo, stress ECG, and stress nuclear imaging were not helpful in identifying endothelium-dependent dysfunction (decrease in coronary blood flow ≤ 50% after intracoronary acetylcholine (Ach)), as well as endothelium-independent dysfunction (coronary flow reserve (CFR) ≤ 2.5 after intracoronary adenosine). This study has never been replicated, nor has it been evaluated using more contemporary invasive methods and more comprehensive non-invasive measures.

Our aim was to investigate the diagnostic value of comprehensive noninvasive stress testing, including stress echo, stress ECG, and non-ECG stress testing parameters in identifying symptomatic women and men with non-obstructive CAD who underwent contemporary invasive testing for an occult coronary abnormality as a cause of their angina.

2. METHODS

2.1. Study Population

We retrospectively analyzed 155 adult patients (133 stress echo, 22 exercise treadmill tests) with typical (64.9%) or atypical (35.1%) angina who had been found to have non-obstructive CAD (stenosis <50%) on CA. Patients were electively referred to the cardiac catheterization for CA because of a clinical suspicion of coronary ischemia based on persistent anginal symptoms for at least three months despite medical therapy with or without an abnormal stress test. A baseline coronary angiogram was performed via the femoral artery to rule out obstructive CAD in the right and left coronary arteries. These patients additionally underwent invasive testing to evaluate for an underlying coronary pathophysiology as a cause of their angina, including endothelial dysfunction, MVD, or an MB.[2] We excluded those with an acute coronary syndrome, prior heart transplantation, coronary artery bypass grafting, renal insufficiency (creatinine>1.5mg/dL), EF < 55%, or another likely explanation of angina such as pulmonary hypertension, hypertrophic cardiomyopathy, or valvular heart disease.

Stress tests were ordered at the discretion of the treating physician as an evaluation for angina. The stress tests included an exercise or dobutamine stress echo, or an exercise treadmill test, according to standard laboratory protocols. All stress tests were performed before invasive coronary testing. All patients ultimately underwent CA, either because of a positive stress test or because of persistent anginal symptoms despite a negative stress test. The study was approved by the Stanford Institutional Review Board, and informed, written consent was obtained from all patients.

2.2. Invasive Coronary Testing

After CA, patients underwent further invasive evaluation for endothelial dysfunction, MVD, and an MB, as described previously.[2] In brief, we tested coronary endothelial function by administering up to 200 μg of intracoronary Ach into the left main coronary artery. Endothelial dysfunction was diagnosed if the epicardial coronary artery diameter decreased by >20% compared to baseline on quantitative coronary angiography.[12]

Next, we measured the index of microcirculatory resistance (IMR) in the left anterior descending artery (LAD) using a pressure-temperature sensor guidewire (Certus Pressure Wire, St. Jude, St. Paul, MN). Resting mean transit time (Tmn) and hyperemic Tmn were calculated by administering 3 ml of intracoronary saline. Maximal hyperemia was achieved using intravenous adenosine. Simultaneous measurements of mean aortic pressure (Pa, by guiding catheter) and mean distal coronary pressure (Pd, by pressure wire) were also made during maximal hyperemia. IMR was calculated as the Pd at maximal hyperemia divided by the inverse of the hyperemic Tmn.[13] MVD was defined as an IMR ≥25.[14] IMR was chosen over CFR in defining the presence of MVD because it has been shown to be a more accurate measure of the coronary microvasculature and is not affected by sex differences in resting coronary flow.[14,15]

IVUS was performed with a 40-MHz mechanical transducer ultrasound catheter (Boston Scientific, Marlborough, MA) in the LAD. All measurements were performed offline by the Stanford IVUS Core Laboratory, blinded to other testing. The presence of an MB was defined by the presence of an echolucent half-moon sign and systolic compression ≥10%.[16] Figure 1 shows an example of endothelial dysfunction, MVD, and an MB.

Figure 1. Demonstrative example of occult coronary abnormalities in patients with angina in the absence of obstructive CAD.

Figure 1.

(A) Coronary angiogram with diffuse vasoconstriction after 100 μg intracoronary acetylcholine demonstrating diffuse epicardial endothelial dysfunction. (B) Coronary physiology measurements demonstrating microvascular dysfunction with an IMR of 32.7. (C) Still frame of intravascular ultrasound (IVUS) inside a myocardial bridge. Arrows point to characteristic echolucent half-moon sign (halo), with a thickness of 0.45 mm.

2.3. Stress Echocardiography Testing

Stress echocardiography was performed according to the American Society of Echocardiography recommendations.[17] A standard Bruce protocol was used for exercise testing.[18] Patients exercised until their heart rate reached 85% of maximum predicted for age or due to exercise-limiting symptoms. For dobutamine stress echo, dobutamine was administered starting at a dose of 5 μg/kg/min, to up to 50 μg/kg/min, with up to 1 mg of atropine given as needed to reach target heart rate.[17]

Echocardiography was performed using a commercially available echo system (Philips Healthcare, Andover, MA). An average of 5 to 10 beats per loop was recorded at rest and post-stress. All standard echocardiographic views were obtained when possible and analyzed on an offline Xcelera workstation at normal speed, in slow motion, and frame-by-frame. The left ventricle was divided into 16 segments.[19] Segmental wall motion was scored as: normal = 1; hypokinetic = 2; akinetic = 3; and dyskinetic = 4. Inadequately visualized segments were not scored. Stress echo was considered positive when one ventricular segment score increased by ≥ one grade at peak stress. The wall motion score index (WMSI) was derived by dividing the sum of individual visualized segment scores by the number of visualized segments.[20]

We also analyzed a subgroup of stress echocardiograms for the presence of focal septal buckling with apical sparing during end-systole to early-diastole.[21] These images were analyzed by a senior echocardiologist (I.S.), who was blinded to other testing.

2.4. Stress Electrocardiography Testing

A 12 lead ECG was obtained at each stage during exercise. The PR-segment was considered as an isoelectric line and ST-segment amplitude was measured at 60 ms from the J point. A positive ECG was defined as the appearance of horizontal/downsloping ST-segment depressions of ≥ 1 mm for an exercise study and ≥ 0.5 mm for a dobutamine study in at least two contiguous leads for three consecutive beats at maximum achieved heart rate.[10] Interobserver agreement for ECG coding reached substantial, with a kappa score of 0.63.

2.5. Non-Electrocardiographic Exercise Parameters

In patients who underwent exercise stress testing (with or without echo), we analyzed non-ECG exercise parameters, including the Duke Treadmill Score (DTS), heart rate recovery (HRR), metabolic equivalents (METs), and blood pressure response. The DTS was calculated as exercise time × (5×ST-segment deviation) - (4×exercise angina), with 0 = no angina, 1 = non-limiting angina, and 2 = exercise-limiting angina.[22] DTSs were categorized as low risk (≥ +5), moderate risk (−10 to +4) and high risk (≤ −11). HRR was defined as peak HR minus HR one minute into recovery.[23,24] Abnormal HRR was defined as a decrease in the HR of ≤ 12 beats per minute.[23] Abnormal blood pressure response was defined as a failure of systolic blood pressure to rise at least 10 mmHg after the first minute of exercise or initial rise in blood pressure but subsequent fall by more than 20 mmHg during exercise.[25]

2.6. Combined Interpretation of Stress Test Parameters

We studied if combining the results of echo, ECG, and non-ECG exercise parameters into a comprehensive interpretation of stress test might improve diagnostic accuracy in identifying occult coronary abnormalities. A positive comprehensive stress test was defined as a positive stress echo and/or positive stress ECG and/or positive non-ECG exercise parameters.

2.7. Statistical Analysis

Normality of the data was verified using the Kolmogorov–Smirnov test and histogram plots. Results are expressed as mean ± standard deviation for parametric, and median (interquartile range) for non-parametric data. Chi-square tests were used for differences between categorical variables. T-tests or Mann-Whitney rank-sum tests were used to assess differences between continuous variables. The association between stress test variables and an occult coronary abnormality was tested using multivariable logistic regression analyses adjusted for confounding variables, including age, body mass index (BMI), and diabetes mellitus.[2] In addition, regression analysis to study the association of HRR to with an occult coronary abnormality was also adjusted for beta-blocker and calcium channel blocker usage.[23,26] A p-value <0.05 was considered significant. Statistical analyses were performed using SPSS 22 (IBM, Armonk, NY) and NCSS 11 (NCSS, Kaysville, UT).

3. RESULTS

Table 1 shows the clinical characteristics of the study patients. There were 119 (76.7%) women with a mean age of 54.1 ± 12.2 years and 36 (23.3%) men with a mean age of 53.7 ± 14.1 years. Women had a higher prevalence family history of CAD, higher total cholesterol, LDL, HDL, lipoprotein (a), and high sensitivity C-reactive protein (hs-CRP). Men had higher levels homocysteine.

Table 1.

Clinical characteristics

Characteristic Women N = 119 Men N = 36 p value
Age, yr 54.1 ± 12.2 53.7 ± 14.1 0.97
Body mass index, kg/m2 25.9 (24.9 – 28.7) 27.4 (24.9 – 28.9) 0.39
Hypertension 62 (52.1) 13 (36.1) 0.97
Diabetes mellitus 18 (15.3) 7 (19.4) 0.53
Dyslipidemia 69 (57.9) 21 (58.3) 0.97
Current Smoking 15 (12.6) 7 (19.4) 0.10
Family history of CAD 37 (31.1) 5 (13.9) 0.04
Medications
 Aspirin 76 (63.8) 28 (77.8) 0.27
 Beta blockers 52 (43.7) 17 (47.2) 0.81
 ACEI/ARB 18 (15.1) 8 (22.2) 0.53
 Diuretics 17 (14.3) 1 (2.8) 0.13
 Statins 66 (55.5) 23 (63.9) 0.59
 CCB 22 (18.5) 10 (27.8) 0.42
 Nitrates 51 (42.9) 18 (50.0) 0.66
Total cholesterol, mg/dL 168.8 ± 39.5 142.7 ± 28.2 < 0.01
Triglycerides, mg/dL 68 (53 – 76) 62 (45 – 77) 0.81
LDL, mg/dL 96.9 ± 34.5 80.5 ± 25.8 0.007
HDL, mg/dL 55 (51 – 58) 44 (39 – 53) 0.002
Lipoprotein (a), mg/dL 14.1 (10.3 – 16.2) 22.2 (10.8 – 32.7) 0.02
Fasting glucose, mg/dL 94 (90 – 96) 98 (91 – 106) 0.16
HbAlc, % 5.4 (5.4 – 5.7) 5.6 (5.4 – 5.8) 0.33
hs-CRP, mg/L 1.2 (1.0 – 1.9) 0.6 (0.4 – 1.9) 0.03
Homocysteine, μmol/L 7.3 (6.8 – 7.7) 8.9 (7.8 – 9.9) < 0.01

ACEI = angiotensin converting enzyme inhibitors; ARB = angiotensin receptor blockers; CAD = coronary artery disease; CCB = calcium channel blocker; HbA1c = hemoglobin A1c; hs-CRP = high sensitivity C-reactive protein. Variables are expressed as mean ± SD, n (%) or median (interquartile range) depending on normality criteria.

Of the 155 patients, 150 underwent endothelial function and microvascular testing, while 154 had IVUS. Endothelial dysfunction was present in 96 (64%) (74 women, 22 men), while 32 (20.6%) (25 women, 7 men) had MVD and 83 (53.9%) (61 women, 22 men) had an MB. The median duration between stress test and invasive testing was 48 (17 – 114) days. Stress echo was positive in 58 (43.6%) (42 women, 16 men), while 57 (36.7%) (49 women, 8 men) had a positive stress ECG. Appendix Table 1 shows the stress echo and ECG parameters in patients with endothelial dysfunction, MVD, and/or an MB. We found no significant differences between the groups.

3.1. Stress Echocardiographic Findings

The sensitivity and specificity of stress echo to identify the presence of any occult coronary abnormality was low to moderate in both sexes (Figure 2(A)). On multivariable regression analysis, stress echo was not associated with the presence of any occult coronary abnormality (Table 2).

Figure 2(A). Sensitivity, specificity, PPV, NPV of stress echo in identifying the presence of any abnormality, endothelial dysfunction, microvascular dysfunction, and myocardial bridge.

Figure 2(A).

CI = confidence interval, NPV = negative predictive value, PPV = positive predictive value

Table 2.

Multivariable logistic regression analysis for the diagnostic value of stress echo and ECG in predicting endothelial dysfunction, microvascular dysfunction, and a myocardial bridge.

All patients Women Men

Diagnostic test Abnormality Odd’s ratio* (95% CI) p value Odd’s ratio* (95% CI) p value Odd’s ratio* (95% CI) p value
Stress echo Any abnormality 2.71 (0.93 – 6.73) 0.06 2.10 (0.78 – 5.68) 0.14 3.91 (0.26 – 59.6) 0.32
Endothelial dysfunction 1.66 (0.77 – 3.58) 0.19 1.30 (0.55 – 3.07) 0.54 4.23 (0.55 – 32.4) 0.16
MVD 1.08 (0.44 – 2.69) 0.85 0.79 (0.28 – 2.26) 0.66 1.05 (0.37 – 2.96) 0.91
MB 1.98 (0.97 – 4.04) 0.059 1.88 (0.82 – 4.29) 0.13 1.45 (0.30 – 6.98) 0.64
Stress ECG Any abnormality 2.11 (1.86 – 5.16) 0.03 1.88 (1.35 – 4.83) 0.043 2.01 (0.72 – 5.59) 0.18
Endothelial dysfunction 2.13 (1.01 – 4.49) 0.047 2.38 (1.04 – 5.45) 0.03 1.10 (0.17 – 6.99) 0.91
MVD 1.05 (0.45 – 2.46) 0.90 1.00 (0.39 – 2.59) 0.99 0.67 (0.06 – 7.48) 0.75
MB 0.85 (0.43 – 1.64) 0.62 0.64 (0.30 – 1.36) 0.24 6.70 (0.56 – 80.0) 0.13
Any abnormality 2.85 (1.13 – 7.21) 0.02 2.29 (1.80 – 6.51) 0.01 7.41 (0.52 – 104.6)
Comprehensive stress test Endothelial dysfunction 2.21 (1.78 – 5.03) 0.03 2.22 (1.88 – 5.59) 0.041 2.06 (0.27 – 15.6) 0.48
MVD 1.82 (0.61 – 5.45) 0.27 1.10 (0.34 – 3.55) 0.87 0.57 (0.15 – 5.63) 0.85
MB 1.55 (0.72 – 3.35) 0.26 1.56 (0.63 – 3.83) 0.33 0.85 (0.14 – 5.31) 0.86

CI = confidence interval; Echo = echocardiogram; ECG = electrocardiogram; MB = myocardial bridge; MVD = microvascular dysfunction

* =

adjusted for age, BMI, and diabetes mellitus

† =

comprehensive stress test is defined as positive stress echo and/or positive stress ECG and/or positive non-ECG stress testing parameter

We analyzed a subset of the population consisting of 65 patients (45 women, 20 men) for the presence of focal septal buckling with apical sparing during stress echocardiography in identifying the presence of an MB. Of these patients, 44 (67.7%) had an MB by IVUS and 51 (78.5%) had focal septal buckling on stress echo. With the addition of this echocardiographic characteristic, the sensitivity and specificity of stress echo were 86.4% and 38.1% respectively. For women, the results were similar, with a sensitivity of 84.4% and a specificity of 15.4%, whereas for men, both the sensitivity and specificity improved to 91.7% and 75.0%, respectively. On multivariable regression analysis, focal septal buckling was associated with the presence of an MB (OR 4.08; 95% CI 1.15 – 14.4; p = 0.02).

3.2. Stress Electrocardiographic Findings

The specificity of stress ECG to identify any occult coronary abnormality, endothelial dysfunction, MVD, or an MB was better than that of stress echo, whereas the sensitivity was poor (Figure 2(B)). On multivariable regression analysis, stress ECG was associated with the presence of any abnormality and endothelial dysfunction in women, but not in men. Stress ECG was not associated with the presence of MVD or an MB in either sex.

Figure 2(B). Sensitivity, specificity, PPV, NPV of stress ECG in identifying the presence of any abnormality, endothelial dysfunction, microvascular dysfunction, and myocardial bridge.

Figure 2(B).

CI = confidence interval, NPV = negative predictive value, PPV = positive predictive value

3.3. Analysis of Non-Electrocardiographic Exercise Parameters

There was no difference in the DTS, METs, or blood pressure response between those with occult coronary abnormalities vs. those without, although patients with an occult coronary abnormality had a moderately high risk DTS. Conversely, there was a significantly higher prevalence of abnormal HRR in those with endothelial dysfunction vs. those without (17 (17.7%) vs. 2 (2.1%); p = 0.03). This was true for women (14 (18.9%) vs. 1 (2.2%); p = 0.041), but not for men. Women with MVD also had a significantly higher prevalence of abnormal HRR vs. those without (49 (36%) vs. 10 (10.6%); p = 0.02), while men did not. There was no difference in the prevalence of abnormal HRR in patients with an MB vs. those without. On multivariable regression analysis, abnormal HRR was associated with endothelial dysfunction (OR 4.65; 95% CI 1.96 – 32.9; p = 0.048) and MVD (OR 3.85; 95% CI 1.31 – 17.8; p = 0.04).

3.4. Combined Interpretation of Stress Testing Parameters

The use of a comprehensive stress test to identify an occult coronary abnormality, by combining the results of echo, ECG, and non-ECG exercise parameters, greatly improved the sensitivity, although the specificity remained low to moderate (Figure 2(C)). On multivariable regression analysis, a comprehensive stress test was associated with the presence of any occult coronary abnormality (OR 2.85; 95% CI 1.13 – 7.21; p = 0.02) and endothelial dysfunction (2.21; 95% CI 1.78 – 5.03; p = 0.03).

Figure 2(C). Sensitivity, specificity, PPV, NPV of comprehensive stress test in identifying the presence of any abnormality, endothelial dysfunction, microvascular dysfunction, and myocardial bridge.

Figure 2(C).

CI = confidence interval, NPV = negative predictive value, PPV = positive predictive value

4. DISCUSSION

In this study, we characterize in detail the diagnostic value of noninvasive stress testing, including stress echocardiography, electrocardiography, and non-ECG exercise parameters, in identifying occult coronary abnormalities in both women and men who have undergone comprehensive invasive testing for angina and non-obstructive CAD. Importantly, we found that stress echo was not associated with any occult coronary abnormality. However, when septal buckling with apical sparing was specifically evaluated, it was associated with the presence of an MB. Stress ECG was associated with any occult coronary abnormality, and endothelial dysfunction in women but failed to associate with MVD or an MB in either sex. Notably, abnormal HRR was associated with endothelial dysfunction and MVD but not with the presence of an MB. Finally, we found that the sensitivity of a stress test improved when non-ECG exercise parameters were considered along with echo and ECG. Our findings strongly suggest the need to reconsider the current approach to the evaluation and management of patients with angina in the absence of obstructive CAD.

It is not necessarily surprising that conventional stress tests were not helpful in identifying occult coronary abnormalities in patients with angina and non-obstructive CAD. These tests were validated to detect obstructive epicardial disease in large vascular territories, and have moderate sensitivity and specificity for subtler levels of ischemia, including smaller obstructed vessels that may go undetected.[27] With endothelial dysfunction, there is an imbalance between the endothelium-derived relaxing factors (nitric oxide) and endothelium-derived constrictors (endothelin), resulting in an inability to appropriately increase coronary blood flow through coronary vasodilatation during stress.[28] This imbalance in supply and demand causes ischemia, which is generally limited to the subendocardium, with preserved transmural perfusion.[29] Such ischemia may cause depolarization changes, resulting in ST-segment depression,[11] but may not induce wall motion abnormalities, which requires a flow reduction >50%, and involvement of ≥20% of transmural wall thickness and ~5% of the total myocardial mass.[30]

Similarly, the coronary microvasculature facilitates the supply and demand by reacting to changes in shear stress and intravascular pressure. With MVD, the coronary vascular resistance is increased, hampering the ability to preserve adequate perfusion pressure in the distal arteriolar bed.[31] Ischemia by MVD can be focal, heterogeneous, and scattered in small regions throughout the myocardium.[32,33] This type of ischemia may cause minor depolarization changes unable to produce significant ST-segment depression, let alone abnormal wall motion. Our results are consistent with previous studies, demonstrating the limited diagnostic accuracy of stress imaging, while stress ECG is the most specific test in identifying endothelial dysfunction.[11,34]

MBs are a common anatomical variant, with a varying prevalence, ranging from 25% using invasive imaging to 85% in autopsy studies.[35,36] The rate of detection of MBs depends on the cohort studied and the imaging test performed. Although MBs are considered benign, a small subset of the population appears to have angina from a hemodynamically significant MB. The pathophysiology of ischemia caused by an MB is also considered to be different than that of obstructive CAD. With an MB, there is delay in vessel relaxation at end-systole/early-diastole, impairing coronary blood flow, particularly at stress.[37] In addition, the location of this ischemia has been proposed to be focal, located within the MB where arising septal branches may have limited perfusion.[21] Previously, we reported that this ischemia is associated with a particular motion of focal septal buckling with apical sparing during stress echo.[21] In this study we found that this abnormal motion is associated with the presence of an MB, with high sensitivity and moderate specificity.

As per our expectation, occult coronary abnormalities were associated with stress ECG changes. It has long been recognized that stress ECG is relatively poor at predicting obstructive CAD, and women in particular have higher rates of false positive stress ECGs than men.[38,39] We hypothesized that the false positive stress ECG changes were due to previously undetected occult coronary abnormalities, which appears to be the case. The higher specificity of stress ECG to detect occult coronary abnormalities, which may have previously gone undetected, may reduce the overall false positive rate of stress ECG.

In evaluating non-ECG exercise parameters, we found that an abnormal HRR was associated with endothelial dysfunction and MVD. This is similar to a previous study demonstrating that an attenuated HRR independently predicted the presence of endothelial dysfunction.[26] Abnormal HRR has been shown to be an independent predictor of both all-cause and cardiovascular mortality in women and men.[23,24] In addition, guidelines have recommended integrating this parameter when analyzing an exercise stress test to improve its diagnostic value.[10] The delay in early recovery of heart rate after termination of exercise is due to persistent activation of the sympathetic nervous system (SNS) and delayed/reduced activation of the parasympathetic nervous system.[40,41] This increased activation of the SNS may markedly suppress endothelium-dependent flow mediated dilatation via a specific inhibitory effect on the release of nitric oxide.[42] Likewise, animal studies have shown that chronic persistent activation of the SNS causes increased endothelial cell injury/dysfunction mediated by beta-1 adrenergic receptors.[43] HRR was associated with endothelial dysfunction and MVD in women, but not men. This may be due to the small number of men in this study or a true sex difference. Our findings support the addition of HRR to stress testing when evaluating patients with angina and non-obstructive CAD.

Finally, combining the results of echo, ECG, and non-ECG exercise parameters into a comprehensive stress test interpretation appears to improve the accuracy of diagnosing an occult coronary abnormality. Still, better non-invasive tests are needed. Promising work has been done with positron emission tomography (PET), magnetic resonance imaging (MRI) and Coronary CT Angiography,[4448] but comprehensive invasive coronary testing remains essential to gaining important diagnostic information that may affect treatment and outcomes in symptomatic patients with non-obstructive CAD.[2] In the future, we expect that providers will better understand that conventional stress tests are designed to evaluate for obstructive CAD, but fail to adequately rule out a coronary etiology of non-obstructive CAD. In addition, as research continues, we anticipate that improved non-invasive tests that can identify subtleties of ischemia will become available to aid providers in diagnosing these patients, which will ultimately improve and guide management. Until then, non-invasive guidelines should emphasize the inadequacy of conventional stress testing in patients with angina, but a low pre-test probability of obstructive CAD, and guidelines and appropriate use criteria for diagnostic catheterization should better reflect the need for invasive testing in this large and poorly understood population.

4.1. Limitations

This study was retrospective, but the invasive tests were done prospectively, and non-invasive testing was always performed before invasive testing, hence we do not think that the retrospective nature of this study will significantly alter the results of our study. The study had a relatively smaller sample size with majority of women, but this is reflective of the population with angina and non-obstructive CAD. Stress testing was limited to echocardiography and electrocardiography, and did not include alternatives, such as nuclear perfusion scanning, MRI, or PET. Likewise, invasive testing was performed in the LAD only and may have missed abnormalities in other territories. In addition, there is the risk of selection bias since our cohort of patients had persistent anginal symptoms despite medical therapy that were considered severe enough to warrant invasive testing. These results may not be generalizable to patients with mild symptoms or those controlled with medical therapy alone, although the prevalence of endothelial dysfunction and microvascular dysfunction in our study was consistent with previous studies.[12,49] In addition, there would be no reason to believe that stress testing would be any more valuable in those with less significant symptoms. Finally, outcome data was not available for this study, although previous studies have reported adverse outcomes with these abnormalities and have documented improvement with treatment in this patient population.[12,49]

5. CONCLUSION

Conventional stress testing with echo and ECG have limited diagnostic accuracy for identifying occult coronary abnormalities that may cause angina in patients with non-obstructive CAD. Stress ECG is associated with the presence of an occult coronary abnormality in women, which may explain the high rate of false positives commonly noted in women with angina and non-obstructive CAD. Likewise, the addition of non-ECG exercise parameters, particularly heart rate recovery, in the interpretation of a stress test may provide important diagnostic information regarding an underlying occult coronary abnormality. Still, the presence of a normal noninvasive stress test does not rule out an occult coronary abnormality, and further studies are needed to clarify the best approach for the evaluation and management of patients with angina in the absence of obstructive CAD.

Highlights.

  • Conventional stress tests have poor diagnostic accuracy in identifying occult coronary abnormalities in patients with angina and non-obstructive CAD

  • Presence of a normal noninvasive stress test does not rule out an occult coronary abnormality

  • Hear rate recovery was associated with presence of endothelial and microvascular dysfunction

Acknowledgments

Funding support: NIH K23 HL092233-05 (PI: JAT)

Financial disclosure: VSP: Research grant; Gilead Sciences. YK: Research grant; Boston Scientific; Travel support; St. Jude Medical. VFF: co-owner of Cardea Associates, Inc.; DPL: Honoraria; Abbott Vascular, Boston Scientific, Medtronic. WFF: Research support; Medtronic, Abbott, Acist Medical, CathWorks; Consultant; Heartflow. ACY: Research grant; Boston Scientific, Edwards, Medtronic; Honoraria: Abbott Vascular, Medtronic. JAT: Honoraria; Abbott Vascular, Boston Scientific, Medtronic, Recor, Terumo. Others nothing to disclose.

Abbreviations

CA

coronary angiography

CAD

coronary artery disease

DTS

duke treadmill score

ECG

electrocardiogram

FFR

fractional flow reserve

HRR

heart rate recovery

IMR

index of microcirculatory resistance

IVUS

intravascular ultrasound

METs

metabolic equivalents

MVD

microvascular dysfunction

MB

myocardial bridge

NPV

negative predictive value

PPV

positive predictive value

SNS

sympathetic nervous system

Tmn

mean transit time

WMSI

wall motion score index

APPENDIX

Appendix Table 1.

Stress echocardiographic and electrocardiographic parameters in patients with endothelial dysfunction, microvascular dysfunction, and a myocardial bridge

Characteristic All Subjects (N = 155) Endothelial dysfunction (N = 96) MVD (N = 32) MB (N = 83)
Stress echo *
Positive stress echo, n (%) 58 (43.6) 41 (52.9) 8 (53.3) 31 (57.4)
Rest WMSI Median (min – max) 1 (1 – 1.31) 1 (1 – 1.31) 1 (1 – 1.18) 1 (1 – 1.31)
Stress WMSI Median (min – max) 1 (1 – 1.56) 1 (1 – 1.56) 1 (1 – 1.56) 1 (1 – 1.37)
Septal buckling - - - 38 (86.4)
Stress ECG
Positive stress ECG, n (%) 57 (36.7) 34 (41.5) 5 (22.7) 22 (32.4)
Peak HR (bpm) 157 (142 – 169) 155 (142 – 167) 150 (130 – 161) 159 (143 – 169)
% of predicted HR 93 (87 – 99) 93 (87 – 101) 91 (81 – 98) 94 (88 – 101)
Peak SBP (mmHg) 165 (148 – 180) 167.6 ± 25.5 170.2 ± 25.1 164.4 ± 26.0
Peak DBP (mmHg) 78 (72 – 84) 79.0 ± 12.6 82.8 ± 10.1 78.5 ± 10.4
Exercise time (min) 9.13 (7.00 – 11) 9.16 (7.01 – 11.3) 7.7 (6.3 – 9.9) 9.3 (7 – 11)
METs 10.5 ± 3.3 10.2 ± 3.2 9.4 ± 2.8 10.6 ± 3.6
Duke Treadmill Score −2 (−7 – 3) −1 (−7 – 1) −3 (−7 – 4) −1 (−6 – 4)
Chest pain, n (%) 83 (53.5) 50 (52.1) 16 (50) 48 (57.8)

bpm = beats per minute; DBP = diastolic blood pressure; HR = heart rate; METs = metabolic equivalent term; min = minimum; max = maximum; SBP = systolic blood pressure; WMSI = wall motion score index

* =

n = 133

† =

data available for 65 patients

‡ =

n =155

Footnotes

All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • [1].Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, V Anderson H, Brindis RG, Douglas PS, Low diagnostic yield of elective coronary angiography, N Engl J Med. 362 (2010) 886–895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA, Invasive Evaluation of Patients with Angina in the Absence of Obstructive Coronary Artery Disease, Circulation. 131 (2015) 1054–1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey S, Arnsdorf M, Black HR, Pepine CJ, Merz CNB, Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease, Arch. Intern. Med. 169 (2009) 843–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Shaw L, Merz C, Pepine C, Reis S, Bittner V, The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease, Circulation. 114 (2006) 894–904. [DOI] [PubMed] [Google Scholar]
  • [5].Jespersen L, Abildstrom SZ, Hvelplund A, Madsen JK, Galatius S, Pedersen F, Hojberg S, Prescott E, Burden of Hospital Admission and Repeat Angiography in Angina Pectoris Patients with and without Coronary Artery Disease: A Registry-Based Cohort Study, PLoS One. 9 (2014) e93170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Arbab-Zadeh A, Fuster V, The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography., J. Am. Coll. Cardiol. 68 (2016) 2467–2478. [DOI] [PubMed] [Google Scholar]
  • [7].Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Dasgupta N, Biro S, Dani L, Dangas GD, Mehran R, Kirtane AJ, Lansky AJ, Kreps EM, Collins MB, Stone GW, Moses JW, Leon MB, Comparison of Angiographic and Intravascular Ultrasonic Detection of Myocardial Bridging of the Left Anterior Descending Coronary Artery, Am. J. Cardiol. 102 (2008) 1608–1613. [DOI] [PubMed] [Google Scholar]
  • [8].Kern MJ, Lerman A, Bech J-W, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NHJ, Siebes M, Spaan J. a E, Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology., Circulation. 114 (2006) 1321–1341. [DOI] [PubMed] [Google Scholar]
  • [9].Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, Kaski JC, Bairey Merz CN, International standardization of diagnostic criteria for microvascular angina, Int. J. Cardiol. 250 (2018) 16–20. [DOI] [PubMed] [Google Scholar]
  • [10].Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RYK, Lim MJ, Linderbaum JA, MacK MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV, 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, J. Am. Coll. Cardiol. 60 (2012) e44–e164. [DOI] [PubMed] [Google Scholar]
  • [11].Cassar A, Chareonthaitawee P, Rihal CS, Prasad A, Lennon RJ, Lerman LO, Lerman A, Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease, Circ. Cardiovasc. Interv. 2 (2009) 237–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, David R, Lerman A, Long-Term Follow-Up of Patients with Mild Coronary Artery Disease and Endothelial Dysfunction, Circulation. 101 (2000) 948–954. [DOI] [PubMed] [Google Scholar]
  • [13].Fearon WF, Balsam LB, Farouque HMO, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC, Novel index for invasively assessing the coronary microcirculation, Circulation. 107 (2003) 3129–3132. [DOI] [PubMed] [Google Scholar]
  • [14].Ng MKC, Yeung AC, Fearon WF, Invasive assessment of the coronary microcirculation: Superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve, Circulation. 113 (2006) 2054–2061. [DOI] [PubMed] [Google Scholar]
  • [15].Kobayashi Y, Fearon WF, Honda Y, Tanaka S, Pargaonkar V, Fitzgerald PJ, Lee DP, Stefanick M, Yeung AC, Tremmel JA, Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease, JACC Cardiovasc. Interv. 8 (2015) 1433–1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Ge J, Jeremias A, Rupp A, Abels M, Baumgart D, Liu F, Haude M, Görge G, Von Birgelen C, Sack S, Erbel R, New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler, Eur. Heart J. 20 (1999) 1707–1716. [DOI] [PubMed] [Google Scholar]
  • [17].Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG, American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J. Am. Soc. Echocardiogr. 20 (2007) 1021–1041. [DOI] [PubMed] [Google Scholar]
  • [18].Bruce RA, Lovejoy FW, Normal respiratory and circulatory pathways of adaptation in exercise., J. Clin. Invest. 28 (1949) 1423–1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Roger VL, Pellikka PA, Oh JK, Miller FA, Seward JB, Tajik AJ, Stress Echocardiography. Part I. Exercise Echocardiography: Techniques, Implementation, Clinical Applications, and Correlations, Mayo Clin. Proc. 70 (1995) 5–15. [DOI] [PubMed] [Google Scholar]
  • [20].Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU, Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging, Eur. Heart J. Cardiovasc. Imaging. 16 (2015) 233–271. [DOI] [PubMed] [Google Scholar]
  • [21].Lin S, Tremmel JA, Yamada R, Rogers IS, Yong CM, Turcott R, McConnell MV, Dash R, Schnittger I, A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation., J. Am. Heart Assoc. 2 (2013) e000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Shaw LJ, Peterson ED, Shaw LK, Kesler KL, DeLong ER, Harrell FE Jr., Muhlbaier LH, Mark DB, Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups, Circulation. 98 (1998) 1622–1630. [DOI] [PubMed] [Google Scholar]
  • [23].Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS, Heart-Rate Recovery Immediately after Exercise as a Predictor of Mortality, N. Engl. J. Med. 341 (1999) 1351–1357. [DOI] [PubMed] [Google Scholar]
  • [24].Kohli P, Gulati M, Exercise stress testing in women: Going back to the basics, Circulation. 122 (2010) 2570–2580. [DOI] [PubMed] [Google Scholar]
  • [25].Sanmarco ME, Pontius S, Selvester RH, Abnormal blood pressure response and marked ischemic ST-segment depression as predictors of severe coronary artery disease., Circulation. 61 (1980) 572–578. [DOI] [PubMed] [Google Scholar]
  • [26].Huang PH, Leu HB, Chen JW, Cheng CM, Huang CY, Tuan TC, Ding PYA, Lin SJ, Usefulness of attenuated heart rate recovery immediately after exercise to predict endothelial dysfunction in patients with suspected coronary artery disease, Am. J. Cardiol. 93 (2004) 10–13. [DOI] [PubMed] [Google Scholar]
  • [27].Marwick TH, Stress echocardiography, Heart. 89 (2003) 113–118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A, Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary Angiograms, N. Engl. J. Med. 328 (1993) 1659–1664. [DOI] [PubMed] [Google Scholar]
  • [29].Panting JR, Gatehouse PD, Yang G-Z, Grothues F, Firmin DN, Collins P, Pennell DJ, Abnormal Subendocardial Perfusion in Cardiac Syndrome X Detected by Cardiovascular Magnetic Resonance Imaging, N. Engl. J. Med. 346 (2002) 1948–1953. [DOI] [PubMed] [Google Scholar]
  • [30].Picano E, Stress echocardiography. From pathophysiological toy to diagnostic tool., Circulation. 85 (1992) 1604–1612. [DOI] [PubMed] [Google Scholar]
  • [31].Camici PG, Crea F, Coronary microvascular dysfunction, N. Engl. J. Med. 356 (2007) 830–840. [DOI] [PubMed] [Google Scholar]
  • [32].Maseri A, Crea F, Kaski JC, Crake T, Mechanisms of angina pectoris in syndrome X, J. Am. Coll. Cardiol. 17 (1991) 499–506. [DOI] [PubMed] [Google Scholar]
  • [33].Marroquin OC, Holubkov R, Edmundowicz D, Rickens C, Pohost G, Buchthal S, Pepine CJ, Sopko G, Sembrat RC, Meltzer CC, Reis SE, Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice, Am. Heart J. 145 (2003) 628–635. [DOI] [PubMed] [Google Scholar]
  • [34].Pálinkás A, Tóth E, Amyot R, Rigo F, Venneria L, Picano E, The value of ECG and echocardiography during stress testing for identifying systemic endothelial dysfunction and epicardial artery stenosis, Eur. Heart J. 23 (2002) 1587–1595. [DOI] [PubMed] [Google Scholar]
  • [35].Corban MT, Hung OY, Eshtehardi P, Rasoul-Arzrumly E, McDaniel M, Mekonnen G, Timmins LH, Lutz J, Guyton RA, Samady H, Myocardial bridging: Contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies, J. Am. Coll. Cardiol. 63 (2014) 2346–2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Mohlenkamp S, Hort W, Ge J, Erbel R, Update on myocardial bridging., Circulation. 106 (2002) 2616–2622. [DOI] [PubMed] [Google Scholar]
  • [37].Ge J, Erbel R, Rupprecht HJ, Koch L, Kearney P, Görge G, Haude M, Meyer J, Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging., Circulation. 89 (1994) 1725–1732. [DOI] [PubMed] [Google Scholar]
  • [38].Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, a Colombo D McArthur V. Froelicher, Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis., Circulation. 80 (1989) 87–98. [DOI] [PubMed] [Google Scholar]
  • [39].Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, Marwick TH, Mosca L, Patel AR, Quinones MA, Redberg RF, Taubert KA, Taylor AJ, Thomas GS, Wenger NK, Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Coun, Circulation. 111 (2005) 682–696. [DOI] [PubMed] [Google Scholar]
  • [40].Savin WM, Davidson DM, Haskell WL, Autonomic contribution to heart rate recovery from exercise in humans., J. Appl. Physiol. 53 (1982) 1572–1575. [DOI] [PubMed] [Google Scholar]
  • [41].Huang P-H, Leu H-B, Chen J-W, Lin S-J, Heart rate recovery after exercise and endothelial function--two important factors to predict cardiovascular events., Prev. Cardiol. 8 (2005) 167–170; quiz 171. [DOI] [PubMed] [Google Scholar]
  • [42].Hijmering ML, Stroes ESG, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ, Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation, J. Am. Coll. Cardiol. 39 (2002) 683–688. [DOI] [PubMed] [Google Scholar]
  • [43].Pettersson K, Bejne B, Bjork H, Strawn WB, Bondjers G, Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via β1-adrenoceptor activation, Circ. Res. 67 (1990) 1027–1034. [DOI] [PubMed] [Google Scholar]
  • [44].Schindler TH, Schelbert HR, Quercioli A, Dilsizian V, Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health, JACC Cardiovasc. Imaging. 3 (2010) 623–640. [DOI] [PubMed] [Google Scholar]
  • [45].Yoshinaga K, Manabe O, Tamaki N, Assessment of coronary endothelial function using PET, J. Nucl. Cardiol. 18 (2011) 486–500. [DOI] [PubMed] [Google Scholar]
  • [46].Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M, Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease, J. Am. Coll. Cardiol. 56 (2010) 1657–1665. [DOI] [PubMed] [Google Scholar]
  • [47].Shufelt CL, Thomson LEJ, Goykhman P, Agarwal M, Mehta PK, Sedlak T, Li N, Gill E, Samuels B, Azabal B, Kar S, Kothawade K, Minissian M, Slomka P, Berman DS, Bairey Merz CN, Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls., Cardiovasc. Diagn. Ther. 3 (2013) 153–160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Forsdahl SH, Rogers IS, Schnittger I, Tanaka S, Kimura T, Pargaonkar VS, Chan FP, Fleischmann D, Tremmel JA, Becker H-C, Myocardial Bridges on Coronary Computed Tomography Angiography ― Correlation With Intravascular Ultrasound and Fractional Flow Reserve ―, Circ. J. 81 (2017) 1894–1900. [DOI] [PubMed] [Google Scholar]
  • [49].Lee JM, Layland J, Jung JH, Lee HJ, Echavarria-Pinto M, Watkins S, Yong AS, Doh JH, Nam CW, Shin ES, Koo BK, Ng MK, Escaned J, Fearon WF, Oldroyd KG, Integrated Physiologic Assessment of Ischemic Heart Disease in Real-World Practice Using Index of Microcirculatory Resistance and Fractional Flow Reserve: Insights from the International Index of Microcirculatory Resistance Registry, Circ. Cardiovasc. Interv. 8 (2015) e002857. [DOI] [PubMed] [Google Scholar]

RESOURCES